Region specific expression of NMDA receptor NR1 subunit mRNA in hypothalamus and pons following chronic morphine treatment

European Journal of Pharmacology

Volumn 365, Issue 1, 1999, Pages 47-54

  Zhu, Hong ^a   Jang, Choon Gon ^a   Ma, Tangeng ^a   Oh, Seikwan ^a   Rockhold, Robin W ^a   Ho, Ing K ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

In situ hybridization; Morphine; NMDA receptor; Physical dependence; Tolerance

Indexed keywords

MESSENGER RNA; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OLIGONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG DEPENDENCE; GENE EXPRESSION; HYPOTHALAMUS; IN SITU HYBRIDIZATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; MORPHINE TOLERANCE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS;

ANALGESICS, OPIOID; ANIMALS; BRAIN STEM; DIENCEPHALON; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; MORPHINE; PONS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER;

EID: 0033556403     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00861-9     Document Type: Article

References (49)

1. Aghajanian G.K. Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature. 267:1978;186-188.
2. 2-agonists in locus coeruleus neurons. Brain Res. 371:1986;390-394.
3. Aghajanian G.K., Kogan J.H., Moghaddam B. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res. 636:1994;126-130.
4. Akaoka A., Aston-Jones G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J. Neurosci. 11:1991;3830-3839.
5. Alreja M., Aghajanian G.K. Opiates suppress a resting sodium-dependent inward current and activate an outward potassium current in locus coeruleus neurons. J. Neurosci. 13:1993;3525-3532.
6. Bartanusz V., Aubry J.M., Pagliusi S., Jezova D., Baffi J., Kiss J.Z. Stress-induced changes in messenger RNA levels of N-methyl-D-aspartate and AMPA receptor subunits in selected regions of the rat hippocampus and hypothalamus. Neuroscience. 66:1995;247-252.
7. Chieng B., Christie M.J. Inhibition by opioid acting on μ-opioid receptors of GABAergic and glutamatergic postsynaptic potentials in single rat periaqueductal gray neurons in vitro. Br. J. Pharmacol. 113:1994;303-309.
8. Chieng B., Christie M.J. Local opioid withdrawal in rat single periaqueductal gray neurons in vitro. J. Neurosci. 16:1996;7128-7136.
9. Christie M.J., Williams J.T., Osborne P.B., Bellchambers C.E. Where is the locus in opioid withdrawal? Trends Pharmacol. Sci. 18:1997;134-140.
10. Collingridge G.L., Bliss T.V.P. NMDA receptors - their role in long term potentiation. Trends Neurosci. 10:1987;288-293.
11. Coutinho-Netto J., Abdul-Ghani A., Bradford H.F. Suppression of evoked and spontaneous release of neurotransmitters in vivo by morphine. Biochem. Pharmacol. 29:1980;2777-2780.
12. Crowder J.M., Norris D.K., Bradford H.F. Morphine inhibition of calcium fluxes, neurotransmitter release and protein and lipid phosphorylation in brain slices and synaptosomes. Biochem. Pharmacol. 35:1986;2501-2507.
13. Duman R.S., Tallman J.F., Nestler E.J. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J. Pharmacol. Exp. Ther. 246:1988;1033-1039.
14. Fundytus M.E., Coderre T.J. Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence. Br. J. Pharmacol. 113:1994;1215-1220.
15. Guitart X., Nestler E.J. Identification of morphine- and cyclic AMP-regulated phosphoproteins (MARPPs) in the locus coeruleus and other regions of the rat brain: regulation by acute and chronic morphine. J. Neurosci. 9:1989;4371-4387.
16. Guitart X., Nestler E.J. Second messenger and protein phosphorylation mechanisms underlying opiate addiction: studies in the rat locus coeruleus. Neurochem. Res. 18:1993;5-13.
17. Guitart X., Hayward M., Nisenbaum L.K., Beitner-Johson D.B., Haycock J.W., Nestler E.J. Identification of MARPP-58, a morphine- and cyclic AMP-regulated phosphoprotein of 58 kDA, as tyrosine hydroxylase: evidence for regulation of its expression by chronic morphine in the rat locus coeruleus. J. Neurosci. 10:1990;2649-2659.
18. Harbuz M.S., Lightman S.L. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J. Endocrinol. 122:1989;705-711.
19. Harbuz M.S., Russell J.A., Sumner B.E.H., Kawata M., Lightman S.L. Rapid changes in the content of proenkephalin A and corticotrophin releasing hormone mRNA in the paraventricular nucleus during morphine withdrawal in urethane-anaesthetized rats. Mol. Brain Res. 9:1991;285-291.
20. Hong M., Milne B., Jhamandas K. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus. Brain Res. 623:1993;131-141.
21. Horan P., Ho I.K. The physical dependence liability of butorphanol: a comparative study with morphine. Eur. J. Pharmacol. 203:1991;387-391.
22. Kutsuwada T., Kashiwabuchi N., Mori H., Sakimura K., Kushiya E., Araki K., Meguro H., Masaki H., Kumanishi T., Arakawa M., Mishina M. Molecular diversity of the NMDA receptor channel. Nature. 358:1992;36-41.
23. Lightman S.L., Young W.S. III Changes in hypothalamic preproenkephalin A mRNA following stress and opiate withdrawal. Nature. 328:1987;643-645.
24. Lightman S.L., Young W.S. III Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat. J. Physiol. 403:1988;511-523.
25. Luque J.M., Malherbe P., Richards J.G. Localization of NMDA receptor subunit mRNAs in the rat locus coeruleus. Mol. Brain Res. 29:1995;224-232.
26. Marek P., Ben-Eliyahu S., Gold M., Liebeskind J.C. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in rats. Brain Res. 547:1991;77-81.
27. Marek P., Ben-Eliyahu S., Vaccarino A.L., Liebeskind J.C. Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res. 558:1991;163-165.
28. Meguro H., Mori H., Araki K., Kushiya E., Kutsuwada T., Arakawa M., Sakimura K., Mishina M. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature. 357:1992;70-74.
29. Melis M.R., Stancampiano R., Argiolas A. Penile erection and yawning induced by paraventricular NMDA injection in male rats are mediated by oxytocin. Pharmacol. Biochem. Behav. 48:1994;203-207.
30. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science. 256:1992;1217-1221.
31. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain functions. Science. 258:1992;597-603.
32. Nestler E.J., Tallman J.F. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol. Pharmacol. 33:1988;127-132.
33. Nestler E.J., Erdos J.J., Terwilliger R., Duman R.S., Tallman J.F. Regulation of G proteins by chronic morphine in the rat locus coeruleus. Brain Res. 476:1989;230-239.
34. Nestler E.J., Alreja M., Aghajanian G.K. Molecular and cellular mechanisms of opiate action: studies in the rat locus coeruleus. Brain Res. Bull. 35:1994;521-528.
35. North R.A., Williams J.T. On the potassium conductance increased by opioids in rat locus coeruleus neurons. J. Physiol. 364:1985;265-280.
36. G. Paxinos, C. Watson, 1986. The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, Orlando, FL.
37. Rasmussen K. Afferent effects on locus coeruleus in opiate withdrawal. Prog. Brain Res. 88:1991;207-216.
38. Rasmussen K., Aghajanian G.K. Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesion of the nucleus paragigantocellularis. Brain Res. 505:1989;346-350.
39. Rasmussen K., Beitner-Johnson D., Krystal J.H., Aghajanian G.K., Nestler E.J. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J. Neurosci. 10:1990;2308-2317.
40. Rasmussen K., Fuller R.W., Stockton M.E., Perry K.W., Swinford R.M., Ornstein P.L. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal. Eur. J. Pharmacol. 197:1991;9-16.
41. Roeling T.A., van Erp A.M., Meelis W., Kruk M.R., Veening J.G. Behavioral effects of NMDA injected into the hypothalamic paraventricular nucleus of the rat. Brain Res. 550:1991;220-224.
42. Tokuyama S., Wakabayashi H., Ho I.K. Direct evidence for a role of glutamate in the expression of opioid withdrawal syndrome. Eur. J. Pharmacol. 295:1996;123-129.
43. Tokuyama S., Zhu H., Wakabayashi H., Feng Y., Ho I.K. The role of glutamate in the locus coeruleus during opiate withdrawal and effects of H-7, protein kinase inhibitor, on the action of glutamate in rats. J. Biomed. Sci. 5:1998;45-53.
44. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK801. Science. 251:1991;85-87.
45. Tung C.-S., Grenhoff J., Svensson T.H. Morphine withdrawal responses of rat locus coeruleus neuron are blocked by an excitatory amino acid antagonist. Acta Physiol. Scand. 138:1990;581-582.
46. Zhang T., Feng Y.Z., Rockhold R.W., Ho I.K. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat. Life Sci. 55:1994;PL25-PL31.
47. Zhu H., Ho I.K. NMDA-R1 antisense attenuates morphine withdrawal behaviors. Eur. J. Pharmacol. 352:1998;151-156.
48. Zhu H., Rockhold R.W., Ho I.K. The role of glutamate in physical dependence on opioids. Jpn. J. Pharmacol. 76:1998;1-14.
49. Zimmerman E., Pamg C.N., Branch B., Taylor A.N. ACTH secretion in morphine-dependent male rats. Pharmacologist. 17:1975;237.